Shuttle Pharmaceuticals Holdings, Inc. Announces Pricing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules
GAITHERSBURG, Md., Oct. 29, 2024 ( GLOBE NEWSWIRE ) -- Shuttle Pharmaceuticals Holdings, Inc. ( Nasdaq: SHPH ) ( "Shuttle Pharma" or the "Company" ) , a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation ...
| Ticker |
Sentiment |
Impact |
|
ALGGF
|
Neutral
|
10 %
|
|
GLP
|
Neutral
|
10 %
|
|
SHPH
|
Neutral
|
15 %
|
